Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Portland gets US nod for primary hip:

This article was originally published in Clinica

Executive Summary

Sydney, Australia-based Portland Orthopaedics has been granted US FDA approval to market its modular design M-Cor primary hip in the US. The company will now ramp-up manufacturing ahead of delivery to its exclusive US distributor, Plus Orthopedics. The M-Cor is fixed in the thigh bone (femur) with a traditional hammer and nail method, but has unique, patented methods for assisting the surgeon to obtain ideal fit for each person's anatomy. Portland says the approval constitutes the green light to sell and implant its most important hip product throughout the US. Much of the M-Cor design work was done in the US. The product will be manufactured in Sydney.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT052441

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel